|
| |
| Dr.
ANIL KUMAR SAXENA |
|
| |
|
|
Scientist
- F (Deputy Director)
Medicinal Chemistry Division,
Central Drug Research Institute,
Lucknow 226 001 (India) |
| |
| Phone No. |
+91-522-2212411-18; Extn.
4268 , +91-522-351638 |
| Fax No. |
+91-522-223405 |
| E- mail |
anilsak[at]hotmail dot com |
| Educational qualifications |
M.Sc. Ph.D. |
| Date of birth |
17- 12- 1951
|
|
| |
| POST
DOCTORAL EXPERIENCE |
| |
|
•
|
As Alex.
V. Humboldt Fellow |
|
•
|
Borstel Research
Institute, Germany |
|
| |
| RESEARCH
EXPERIENCE |
| |
|
•
|
33 Year's
research experience in Medicinal Chemistry & 25 years
in CADD & CAMM. |
|
| |
| CURRENT
AREAS OF INTEREST |
|
•
|
Medicinal
Chemistry & Computer Aided Drug Design (CADD). |
|
|
| EDITOR
BOOKS/ JOURNALS |
| |
|
•
|
Guest Editor |
Medicinal
Chemistry Research, Vol. 5, No. 8, 1995 |
|
•
|
Guest Editor |
Medicinal
Chemistry Research, Vol. 10, number 7/8, 2001, Birkhauser
Publication, USA. |
|
•
|
Guest Editor |
SAR and QSAR
in Environmental Research, Vol. 12, number 6, 2001. |
|
•
|
Patent Evaluator |
Current Drugs,
U.K. |
|
| |
| SELECTED
RESEARCH PAPERS |
| |
|
•
|
Agents acting
on the central nervous system-15,2-substituted 1,2,3,4,6,
7,12,12a-octahydroprazino(2',1':6,1)pyrido(3,4-b)indoles.
A new class of central nervous system depressants. A.K.
Saxena, P.C. Jain, N. Anand & P.R. Dua. J. Med. Chem.,
16 (1973), 560. |
|
•
|
Neuroleptic
receptors-stereo-selectivity for neuroleptic enantiomer.
P. Seeman, K. Westman, M. Protiva, J. Jilek. P.C. Jain,
A.K. Saxena, N. Anand, L. Humber & A. Philipp. Eur.
J. Pharma-cology, 56 (1979) 247. |
|
•
|
Synthesis
and QSAR in 2-substituted 1,2,3,4,6,12,12a-octahydropyrzino-(2',1':6,1)pyrido(3,4-b)indoles.
A new class of H1-antagonists. A.K. Saxena, S.Ram, M.K.
Dhaon, M. Saxena, (late) P.C. Jain, G.K. Patnaik &
N. Anand. Ind. J. Chem., 22B (1983), 1224. |
|
•
|
Synthesis,
Biological evaluation and QSAR analysis of [ -(aroylamino)ethyl]
piperazines and -piperidines and [2-[(arylamino)carbonyl]ethyl]piperazines,
-piperidines, -pyrazinopyridoindoles and -pyrazinoisoquinolines.
A new class of potent H1-antagonists. M. Saxena, S.K.
Agarwal, G.K. Patnaik & A.K. Saxena. J. Med. Chem.,
33 (1990), 2970. |
|
•
|
Identification
of a pharmacophore by application of hypothetical active
site lattice (HASL) approach. A.K. Saxena, M. Saxena,
H. Chi & M. Wiese. Med. Chem. Res., 3 (1993), 201. |
|
•
|
Comparison
of molecular properties of D2-receptor antagonists from
different chemical families of neuroleptics. I. Russig,
M. Laquerre, A. Carpy & A.K. Saxena. Med. Chem. Res.,
5 (1995), 631. |
|
•
|
Structure
and molecular properties of (1)-Centbutindole. Comparison
with Haloperidol. I. Rusig, M. Leger, M. Laguerre, A.K.
Saxena & A Carpy. J. Chem. Cryst., 25 (1995), 443. |
|
•
|
Synthesis
and molecular lipophilicity potential profiles of 1-[(3-methylphenyl)-piperazin-1-yl]-3-[thio(4-acetamido)phenyl]propane
: A potential hypotensive agents. J. Rao, R.C. Srimal,
E. Audry, A. Carpy & A.K. Saxena. Med. Chem. Res.,
1 (1991), 95. |
|
| |
| SELECTED
PUBLICATIONS |
| |
|
•
|
Research papers
|
91 |
|
•
|
Review/articles
in Books/Monographs |
16 |
|
•
|
Patents (Granted/
filed) |
52 |
|
•
|
Papers presented
|
78 |
|
•
|
Invited lectures |
47 |
| |
|
| |
|
|
| |
|
| |
|
